Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States
07:30am - 03:35pm EDT - April 6, 2024



Abstract: JNCCN23-0560 https://jnccn.org/view/journal...


Author(s):
Tags: Outcomes and Health Services Research

Display Label Action
High Resolution Poster_Hanna _NCCN 2024_ ESA post-lusp.pdf Download Handout